Saturday, June 30, 2018

Zydus Cadila gets USFDA nod for blood pressure drug

Zydus Cadila gets USFDA nod for blood pressure drug Zydus Cadila today said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure. The approval has been granted for the tablets in strengths of 37.5 mg/25 mg and 75 mg/50 mg.

from Moneycontrol Business News https://ift.tt/2tEouom
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Short-term volatility may persist, but FII flows and economic activity to keep sentiment positive: Vikas Khemani

Vikas Khemani of Carnelian Asset Management remains optimistic about Indian markets, citing a strong domestic growth story and the resolutio...